Vitamin K1 can be used to reverse the effects of<unk> , and heparin or its low molecular weight heparin (LMWH) can be used in an attempt to prevent further clotting. None of these suggested therapies have been studied in clinical trials. Heparin and LMWH act by a different mechanism than<unk> , so these drugs can also be used to prevent clotting during the first few days of<unk>  therapy and thus prevent<unk>  (this is called 'bridging').
Warfarin necrosis
Fibrinolysis syndrome
Anemic infarct
Reperfusion injury
Coronary steal
Post-thrombotic syndrome
Gas gangrene
Ischemia